Irvine, CA, United States of America

Stanislaw Rachwal

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Cortex Pharmaceuticals, Inc.. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stanislaw Rachwal. Retrieved from https://idiyas.com/inventor/stanislaw-rachwal-9wdkzjbt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Stanislaw Rachwal: Innovator in Neuropharmacology

Introduction

Stanislaw Rachwal is a notable inventor based in Irvine, CA, who has made significant contributions to the field of neuropharmacology. His work focuses on enhancing cognitive abilities and addressing various neurological disorders. With a keen interest in the mechanisms of brain function, Rachwal has developed innovative compounds that hold promise for treating conditions related to memory impairment and other cognitive challenges.

Latest Patents

Rachwal holds a patent for "Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses." This invention is particularly relevant for the prevention and treatment of cerebral insufficiency. It aims to enhance receptor functioning in synapses within brain networks that are crucial for higher-order behaviors. The implications of this invention extend to cognitive abilities associated with memory impairment, which can be observed in various dementias. Additionally, it addresses imbalances in neuronal activity that are suggested in disorders such as Parkinson's disease, schizophrenia, and affective disorders. The compounds developed by Rachwal are useful for treating these conditions and provide methods for their application.

Career Highlights

Rachwal's career is marked by his dedication to advancing the understanding of brain function and developing therapeutic solutions. His innovative approach has led to the creation of compounds that target specific neurological pathways, thereby enhancing cognitive function and addressing debilitating disorders. His work is a testament to the potential of scientific research in improving the quality of life for individuals affected by neurological conditions.

Collaborations

Rachwal has collaborated with esteemed colleagues, including Gary A. Rogers and Matthew Allan. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their research.

Conclusion

Stanislaw Rachwal's contributions to neuropharmacology through his innovative patents and collaborative efforts highlight the importance of research in addressing cognitive impairments and neurological disorders. His work continues to pave the way for advancements in treatment options for those affected by these conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…